看起來你不是TradeKey.com的會員。 立即註冊,與全球超過7百萬的進口商和出口商建立聯繫。 点击注册--免费! |
BOOK A CALL
Book Call On Your Favorite Time
Code
🗘

By Signing Up. I agree to TradeKey.com Terms of Use, Privacy Policy, IPR and receive emails related to our services

Contact Us


Shanghai Yudiao Chemistry Technology Co., Ltd

Building A, NO.688,Qiushi Road,Jinshan District,Shanghai,shanghai,China China

免费会员
现在联系
查看電話號碼
查看手機號碼
主页 公司名称 Shanghai Yudiao Chemistry Technology Co., Ltd 产品

产品: 15

raltegravir (free base) API
Raltegravir (free base) API

Raltegravir (MK-0518) is a potent inhibitor of human immunodeficiency virus (HIV) integrase and is clinically effective against viruses resistant to o

现在联系
raltegravir k salt
Raltegravir k salt

871038-72-1, raltegravir, raltegravir K salt, N-(2-(4-(4-fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1, 6-dihydropyrimidin-2-yl)propan-2-yl)-5-met

现在联系
3-iodo-6-nitro-1-(tetrahydropyran-2-yl)-1H-indazole
3-iodo-6-nitro-1-(tetrahydropyran-2-yl)-1H-indazole

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug

现在联系
(E)-6-nitro-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
(E)-6-nitro-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.

现在联系
(E)-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-amine
(E)-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-amine

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug

现在联系
(E)-6-iodo-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
(E)-6-iodo-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug

现在联系
(E)-N-methyl-2-(3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-ylthio)benzamide
(E)-N-methyl-2-(3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-ylthio)benzamide

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.The drug

现在联系
2-mercapto-N-methylbenzamide
2-mercapto-N-methylbenzamide

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.

现在联系
Axitinib API
Axitinib API

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC) and hepatocellular carcinoma.

现在联系
masitinib API
Masitinib API

In vitro, masitinib had greater activity and selectivity against KIT than imatinib, inhibiting recombinant human wild-type KIT with an half inhibitory

现在联系
1-Methyl-5-nitro-1H-benzimidazole-2-butanoic acid ethyl ester
1-Methyl-5-nitro-1H-benzimidazole-2-butanoic acid ethyl ester

Bendamustine was first synthesized in 1963 by Ozegowski and Krebs in East Germany (the former German Democratic Republic).

现在联系
bendamustine HCl  API
Bendamustine HCl API

Bendamustine was first synthesized in 1963 by Ozegowski and Krebs in East Germany (the former German Democratic Republic).

现在联系
(S)-tert-butyl 3-oxo-1-phenylpropylcarbamate
(S)-tert-butyl 3-oxo-1-phenylpropylcarbamate

A panel of four CCR5 monoclonal antibodies (mAbs) recognizing different epitopes on CCR5 was examined in CCR5-mediated cell-cell fusion assay

现在联系
maraviroc API
Maraviroc API

A panel of four CCR5 monoclonal antibodies (mAbs) recognizing different epitopes on CCR5 was examined in CCR5-mediated cell-cell fusion assay

现在联系
2-Amino-2-methylpropane nitrile
2-Amino-2-methylpropane nitrile

Raltegravir (MK-0518) is a potent inhibitor of human immunodeficiency virus (HIV) integrase and is clinically effective against viruses resistant to o

现在联系

联系卖家

至:
Mr. James < Shanghai Yudiao Chemistry Technology Co., Ltd >
我想知道: